![]() |
| Ovarian Neoplasms |
|
Free Subscription
1 Ann Oncol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Ovarian Neoplasms is free of charge.
Rucaparib maintenance for newly diagnosed advanced ovarian cancer: interim
overall survival, progression-free survival, and safety at 5 years of follow-up
from the phase III ATHENA-MONO/GOG-3020/ENGOT-ov45.
Ann Oncol. 2025 Oct 18:S0923-7534(25)04950-6. doi: 10.1016/j.annonc.2025.
PubMed
Abstract available
Circulating tumour cells are a prognostic indicator in advanced high-grade serous
ovarian cancer and are associated with platelets and immune cells following
dissemination.
Br J Cancer. 2025 Oct 10. doi: 10.1038/s41416-025-03227.
PubMed
Abstract available
Survival impact of residual disease and timing of surgery in the management of
advanced-stage low grade serous ovarian cancer: A systematic review and
meta-analysis.
Gynecol Oncol. 2025;203:16-25.
PubMed
Abstract available
Development and optimization of an integrated exercise and nutrition program for
ovarian cancer patients: Phase I of the BENITA multi-center study.
Gynecol Oncol. 2025;202:167-173.
PubMed
Abstract available
High serum LDL promotes EMT and stemness through LDLR/FOXQ1/NF-kappaB1 pathway in
epithelial ovarian cancer.
Oncogene. 2025 Oct 22. doi: 10.1038/s41388-025-03609.
PubMed
Abstract available
Thank you for your interest in scientific medicine.